Alector reports q1 2020 financial results

Alector reports 2020 first quarter financial results and business highlights.alector - collaboration revenue for quarter ended march 31, 2020 was $7.2 million compared to $5.6 million for same period in 2019.alector inc - qtrly loss per share $0.53.alector inc - cash, cash equivalents, & marketable securities were $548.5 million as of march 31, 2020.alector - remains on track with previously stated guidance to initiate pivotal phase 3 study of al001 in ftd-grn patients in 2020.alector - intends to initiate phase 2 study of al002 in alzheimer's disease patients in 2020.alector - believes cash, investments as of march 31, 2020 sufficient to fund anticipated operations through 2022.
ALEC Ratings Summary
ALEC Quant Ranking